Arabic Bulgarian Chinese Croatian Czech Danish Dutch English Estonian Finnish French German Greek Hebrew Hindi Hungarian Icelandic Indonesian Italian Japanese Korean Latvian Lithuanian Malagasy Norwegian Persian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swedish Thai Turkish Vietnamese
Arabic Bulgarian Chinese Croatian Czech Danish Dutch English Estonian Finnish French German Greek Hebrew Hindi Hungarian Icelandic Indonesian Italian Japanese Korean Latvian Lithuanian Malagasy Norwegian Persian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swedish Thai Turkish Vietnamese

definition - Plasminogen activator inhibitor-1

definition of Wikipedia

   Advertizing ▼


Plasminogen activator inhibitor-1

Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1

PAI-1 in complex with the SMB domain of Vitronectin PDB 1OC0
Available structures
PDB Ortholog search: PDBe, RCSB
External IDs OMIM173360 MGI97608 HomoloGene68070 ChEMBL: 3475 GeneCards: SERPINE1 Gene
RNA expression pattern
PBB GE SERPINE1 202627 s at tn.png
PBB GE SERPINE1 202628 s at tn.png
More reference expression data
Species Human Mouse
Entrez 5054 18787
Ensembl ENSG00000106366 ENSMUSG00000037411
UniProt P05121 D0ESZ5
RefSeq (mRNA) NM_000602.3 NM_008871.2
RefSeq (protein) NP_000593.1 NP_032897.2
Location (UCSC) Chr 7:
100.77 – 100.78 Mb
Chr 5:
137.54 – 137.55 Mb
PubMed search [1] [2]

Plasminogen activator inhibitor-1 (PAI-1) also known as endothelial plasminogen activator inhibitor or serpin E1 is a protein that in humans is encoded by the SERPINE1 gene.

PAI-1 is a serine protease inhibitor (serpin) that functions as the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots). It is a serine protease inhibitor (serpin) protein (SERPINE1).

The other PAI, plasminogen activator inhibitor-2 (PAI-2) is secreted by the placenta and only present in significant amounts during pregnancy. In addition, protease nexin acts as an inhibitor of tPA and urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators.



The PAI-1 gene is officially called SERPINE1 and is located on the seventh chromosome (7q21.3-q22). There is a common polymorphism known as 4G/5G in the promoter region. The 5G allele is slightly less transcriptionally active than the 4G.


PAI-1 is mainly produced by the endothelium (cells lining blood vessels), but is also secreted by other tissue types, such as adipose tissue.

PAI-1 inhibits the serine proteases tPA and uPA/urokinase, and hence is an inhibitor of fibrinolysis, the physiological process that degrades blood clots.

PAI-1 inhibits the activity of matrix metalloproteinases, which play a crucial role in invasion of malignant cells across the basal lamina.

Fibrinolysis (simplified). Blue arrows denote stimulation, and red arrows inhibition.

  Role in disease

Congenital deficiency of PAI-1 has been reported; as fibrinolysis is not suppressed adequately, it leads to a hemorrhagic diathesis (a tendency to hemorrhage).

PAI-1 is present in increased levels in various disease states (such as a number of forms of cancer), as well as in obesity and the metabolic syndrome. It has been linked to the increased occurrence of thrombosis in patients with these conditions.

In inflammatory conditions in which fibrin is deposited in tissues, PAI-1 appears to play a significant role in the progression to fibrosis (pathological formation of connective tissue). Presumably, lower PAI levels would lead to less suppression of fibrinolysis and conversely a more rapid degradation of the fibrin.

Angiotensin II increases synthesis of plasminogen activator inhibitor-1, so it accelerates the development of atherosclerosis.


Tiplaxtinin (PAI-039) is a small molecule inhibitor that is being studied for use in the attenuation of remodeling of blood vessels, a result of arterial hypertension and activation of the renin-angiotensin system.[1]


Plasminogen activator inhibitor-1 has been shown to interact with ORM1.[2]


  1. ^ Elokdah H, Abou-Gharbia M, Hennan JK, et al. (July 2004). "Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization". J. Med. Chem. 47 (14): 3491–4. DOI:10.1021/jm049766q. PMID 15214776. 
  2. ^ Boncela, J; Papiewska I, Fijalkowska I, Walkowiak B, Cierniewski C S (Sep. 2001). "Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity". J. Biol. Chem. (United States) 276 (38): 35305–11. DOI:10.1074/jbc.M104028200. ISSN 0021-9258. PMID 11418606. 

  Further reading

  • Mimuro J (1991). "[Type 1 plasminogen activator inhibitor: its role in biological reactions]". Rinsho Ketsueki 32 (5): 487–9. PMID 1870265. 
  • Binder BR, Christ G, Gruber F et al. (2002). "Plasminogen activator inhibitor 1: physiological and pathophysiological roles". News Physiol. Sci. 17: 56–61. PMID 11909993. 
  • Eddy AA (2002). "Plasminogen activator inhibitor-1 and the kidney". Am. J. Physiol. Renal Physiol. 283 (2): F209–20. DOI:10.1152/ajprenal.00032.2002. PMID 12110504. 
  • Schroeck F, Arroyo de Prada N, Sperl S et al. (2003). "Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn". Biol. Chem. 383 (7–8): 1143–9. DOI:10.1515/BC.2002.125. PMID 12437099. 
  • Gils A, Declerck PJ (2004). "The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors". Thromb. Haemost. 91 (3): 425–37. DOI:10.1160/TH03-12-0764. PMID 14983217. 
  • Durand MK, Bødker JS, Christensen A et al. (2004). "Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis". Thromb. Haemost. 91 (3): 438–49. DOI:10.1160/TH03-12-0784. PMID 14983218. 
  • Harbeck N, Kates RE, Gauger K et al. (2004). "Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer". Thromb. Haemost. 91 (3): 450–6. DOI:10.1160/TH03-12-0798. PMID 14983219. 
  • Hertig A, Rondeau E (2004). "Plasminogen activator inhibitor type 1: the two faces of the same coin". Curr. Opin. Nephrol. Hypertens. 13 (1): 39–44. DOI:10.1097/00041552-200401000-00006. PMID 15090858. 
  • Hoekstra T, Geleijnse JM, Schouten EG, Kluft C (2004). "Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk". Thromb. Haemost. 91 (5): 861–72. DOI:10.1267/THRO04050861. PMID 15116245. 
  • Lijnen HR (2005). "Pleiotropic functions of plasminogen activator inhibitor-1". J. Thromb. Haemost. 3 (1): 35–45. DOI:10.1111/j.1538-7836.2004.00827.x. PMID 15634264. 
  • De Taeye B, Smith LH, Vaughan DE (2005). "Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease". Current Opinion in Pharmacology 5 (2): 149–54. DOI:10.1016/j.coph.2005.01.007. PMID 15780823. 
  • Dellas C, Loskutoff DJ (2005). "Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease". Thromb. Haemost. 93 (4): 631–40. DOI:10.1267/THRO05040631. PMID 15841306. 
  • Könsgen D, Mustea A, Lichtenegger W, Sehouli J (2005). "[Role of PAI-1 in gynaecological malignancies]". Zentralblatt für Gynäkologie 127 (3): 125–31. DOI:10.1055/s-2005-836407. PMID 15915389. 
  • Vaughan DE (2005). "PAI-1 and atherothrombosis". J. Thromb. Haemost. 3 (8): 1879–83. DOI:10.1111/j.1538-7836.2005.01420.x. PMID 16102055. 
  • Hermans PW, Hazelzet JA (2007). "Plasminogen activator inhibitor type 1 gene polymorphism and sepsis". Clin. Infect. Dis. 41 Suppl 7: S453–8. DOI:10.1086/431996. PMID 16237647. 
  • Alessi MC, Poggi M, Juhan-Vague I (2007). "Plasminogen activator inhibitor-1, adipose tissue and insulin resistance". Curr. Opin. Lipidol. 18 (3): 240–5. DOI:10.1097/MOL.0b013e32814e6d29. PMID 17495595. 

  External links



All translations of Plasminogen activator inhibitor-1

sensagent's content

  • definitions
  • synonyms
  • antonyms
  • encyclopedia

Dictionary and translator for handheld

⇨ New : sensagent is now available on your handheld

   Advertising ▼

sensagent's office

Shortkey or widget. Free.

Windows Shortkey: sensagent. Free.

Vista Widget : sensagent. Free.

Webmaster Solution


A windows (pop-into) of information (full-content of Sensagent) triggered by double-clicking any word on your webpage. Give contextual explanation and translation from your sites !

Try here  or   get the code


With a SensagentBox, visitors to your site can access reliable information on over 5 million pages provided by Sensagent.com. Choose the design that fits your site.

Business solution

Improve your site content

Add new content to your site from Sensagent by XML.

Crawl products or adds

Get XML access to reach the best products.

Index images and define metadata

Get XML access to fix the meaning of your metadata.

Please, email us to describe your idea.


The English word games are:
○   Anagrams
○   Wildcard, crossword
○   Lettris
○   Boggle.


Lettris is a curious tetris-clone game where all the bricks have the same square shape but different content. Each square carries a letter. To make squares disappear and save space for other squares you have to assemble English words (left, right, up, down) from the falling squares.


Boggle gives you 3 minutes to find as many words (3 letters or more) as you can in a grid of 16 letters. You can also try the grid of 16 letters. Letters must be adjacent and longer words score better. See if you can get into the grid Hall of Fame !

English dictionary
Main references

Most English definitions are provided by WordNet .
English thesaurus is mainly derived from The Integral Dictionary (TID).
English Encyclopedia is licensed by Wikipedia (GNU).


The wordgames anagrams, crossword, Lettris and Boggle are provided by Memodata.
The web service Alexandria is granted from Memodata for the Ebay search.
The SensagentBox are offered by sensAgent.


Change the target language to find translations.
Tips: browse the semantic fields (see From ideas to words) in two languages to learn more.

last searches on the dictionary :

5130 online visitors

computed in 0.094s

I would like to report:
section :
a spelling or a grammatical mistake
an offensive content(racist, pornographic, injurious, etc.)
a copyright violation
an error
a missing statement
please precise:



Company informations

My account



   Advertising ▼